|The clinical utility of urine lipoarabinomannan and the novel point-of-care lateral flow strip test (Determine® TB) for the diagnosis of tuberculosis in hospitalised patients …|
JG Peter, A Haripesad, L Mottay, S Kraus, R Meldau, K Dheda
C94. DETECTING AND PREVENTING TUBERCULOSIS AND DRUG-RESISTANT TUBERCULOSIS …, 2011
|Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial|
G Theron, L Zijenah, D Chanda, P Clowes, A Rachow, M Lesosky, W Bara, ...
The Lancet 383 (9915), 424-435, 2014
|Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting|
G Theron, J Peter, R van Zyl-Smit, H Mishra, E Streicher, S Murray, ...
American journal of respiratory and critical care medicine 184 (1), 132-140, 2011
|Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic …|
JG Peter, LS Zijenah, D Chanda, P Clowes, M Lesosky, P Gina, N Mehta, ...
The Lancet 387 (10024), 1187-1197, 2016
|Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa|
A Boulle, MA Davies, H Hussey, M Ismail, E Morden, Z Vundle, ...
Clinical infectious diseases: an official publication of the Infectious …, 2020
KG Blumenthal, JG Peter, JA Trubiano, EJ Phillips
The Lancet 393 (10167), 183-198, 2019
|Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples|
K Dheda, V Davids, L Lenders, T Roberts, R Meldau, D Ling, L Brunet, ...
PloS one 5 (3), e9848, 2010
|Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?|
G Theron, J Peter, D Dowdy, I Langley, SB Squire, K Dheda
The Lancet infectious diseases 14 (6), 527-532, 2014
|Point‐of‐care diagnosis of tuberculosis: Past, present and future|
K Dheda, M Ruhwald, G Theron, J Peter, WC Yam
Respirology 18 (2), 217-232, 2013
|Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients|
JG Peter, G Theron, R van Zyl-Smit, A Haripersad, L Mottay, S Kraus, ...
European respiratory journal 40 (5), 1211-1220, 2012
|Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments|
J Peter, C Green, M Hoelscher, P Mwaba, A Zumla, K Dheda
Current opinion in pulmonary medicine 16 (3), 262, 2010
|The diagnostic accuracy of the GenoType® MTBDRsl assay for the detection of resistance to second‐line anti‐tuberculosis drugs|
G Theron, J Peter, M Richardson, M Barnard, S Donegan, R Warren, ...
Cochrane Database of Systematic Reviews, 2014
|Xpert MTB/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results?|
G Theron, R Venter, G Calligaro, L Smith, J Limberis, R Meldau, ...
Clinical Infectious Diseases 62 (8), 995-1001, 2016
|Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid|
G Theron, J Peter, R Meldau, H Khalfey, P Gina, B Matinyena, L Lenders, ...
Thorax 68 (11), 1043-1051, 2013
|Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments|
G Theron, J Peter, G Calligaro, R Meldau, C Hanrahan, H Khalfey, ...
Scientific reports 4 (1), 1-10, 2014
|Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden|
RN van Zyl-Smit, A Binder, R Meldau, H Mishra, PL Semple, G Theron, ...
PloS one 6 (12), e28815, 2011
|The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce|
JG Peter, G Theron, TE Muchinga, U Govender, K Dheda
PloS one 7 (7), e39966, 2012
|Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting?|
DI Ling, M Pai, V Davids, L Brunet, L Lenders, R Meldau, G Calligaro, ...
European Respiratory Journal 38 (3), 649-656, 2011
|Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies|
SD Lawn, K Dheda, AD Kerkhoff, JG Peter, S Dorman, CC Boehme, ...
BMC infectious diseases 13 (1), 1-9, 2013
|Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice|
JG Peter, R Lehloenya, S Dlamini, K Risma, KD White, KC Konvinse, ...
The Journal of Allergy and Clinical Immunology: In Practice 5 (3), 547-563, 2017